Selling, General, and Administrative Costs: Walgreens Boots Alliance, Inc. vs Alkermes plc

SG&A Expenses: Walgreens vs. Alkermes - A Decade in Review

__timestampAlkermes plcWalgreens Boots Alliance, Inc.
Wednesday, January 1, 201419990500017992000000
Thursday, January 1, 201531155800022400000000
Friday, January 1, 201637413000023910000000
Sunday, January 1, 201742157800023813000000
Monday, January 1, 201852640800024694000000
Tuesday, January 1, 201959944900023557000000
Wednesday, January 1, 202053882700025436000000
Friday, January 1, 202156097700024586000000
Saturday, January 1, 202260574700027295000000
Sunday, January 1, 202368975100034205000000
Monday, January 1, 202464523800028113000000
Loading chart...

Cracking the code

A Tale of Two Companies: Walgreens Boots Alliance vs. Alkermes

In the ever-evolving landscape of corporate finance, understanding the dynamics of Selling, General, and Administrative (SG&A) expenses is crucial. Over the past decade, Walgreens Boots Alliance, Inc. and Alkermes plc have showcased contrasting trajectories in their SG&A expenditures.

From 2014 to 2023, Walgreens Boots Alliance consistently reported SG&A expenses that were approximately 40 times higher than those of Alkermes. This stark difference highlights the scale and operational complexity of Walgreens, a global retail pharmacy giant, compared to Alkermes, a biopharmaceutical company. Notably, Walgreens saw a steady increase in expenses, peaking in 2023, while Alkermes experienced a more volatile pattern, with a significant rise of over 240% from 2014 to 2023.

These trends underscore the diverse challenges and strategies employed by companies in different sectors, offering valuable insights for investors and analysts alike.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025